gnckКолопроктологияKoloproktologia2073-75562686-7303Russian Association of Coloproctology10.33878/2073-7556-2023-22-1-138-146gnck-1782Research ArticleОБЗОРЫ ЛИТЕРАТУРЫ И МЕТААНАЛИЗLITERATURE REVIEWS AND METAANALYSISКолоректальный рак на фоне язвенного колита (обзор литературы)Colorectal cancer in ulcerative colitis (review)https://orcid.org/0000-0002-5565-615XРасуловА. О.RasulovA. O.

1-е Успенское ш., д. 111, дер. Лапино, Московская обл.,143081

Arsen O. Rasulov

1st Uspenskoe Shosse, 111, Lapino, Moscow region, 143081

https://orcid.org/0000-0002-3024-9283КуликовА. Э.KulikovA. E.

Куликов Артур Эдуардович

1-е Успенское ш., д. 111, дер. Лапино, Московская обл.,143081

Artur E. Kulikov

1st Uspenskoe Shosse, 111, Lapino, Moscow region, 143081

Kulikov_A.E._MD@mail.ruhttps://orcid.org/0000-0001-9992-3822МадьяровЖ. М.MadyarovJ. M.

1-е Успенское ш., д. 111, дер. Лапино, Московская обл.,143081

Jasur M. Madyarov

1st Uspenskoe Shosse, 111, Lapino, Moscow region, 143081

https://orcid.org/0000-0002-2306-407XРасуловЗ. Р.RasulovZ. R.

1-е Успенское ш., д. 111, дер. Лапино, Московская обл.,143081

Zaur R. Rasulov

1st Uspenskoe Shosse, 111, Lapino, Moscow region, 143081

Клинический госпиталь «Лапино» группы компаний «Мать и дитя»Clinical Hospital “Lapino” of the “Mother and Child” Group of companies202321032023221138146Copyright © Расулов А.О., Куликов А.Э., Мадьяров Ж.М., Расулов З.Р., 20232023Расулов А.О., Куликов А.Э., Мадьяров Ж.М., Расулов З.Р.Rasulov A.O., Kulikov A.E., Madyarov J.M., Rasulov Z.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.ruproctology.com/jour/article/view/1782

Язвенный колит (ЯК) — воспалительное заболевание кишечника, поражающее в основном людей молодого возраста. Одним из осложнений ЯК является развитие колоректального рака (КРР). В данном обзоре лите- ратуры рассмотрены эпидемиология, факторы риска развития, диагностика и скрининг, а также лекар- ственная профилактика КРР на фоне ЯК. Кроме того, описана тактика при дисплазии на фоне ЯК и раз- личные варианты хирургического лечения при развитии КРР. Учитывая недостаточность литературных данных для окончательного суждения о подходах к лечению рака толстой кишки (особенно прямой кишки) на фоне ЯК, достаточно актуальным представляется проведение дальнейших исследований по оценке как онкологических, так и функциональных результатов лечения, что может помочь в решении этой важной проблемы.

Ulcerative colitis (UC) is an inflammatory bowel disease that mainly affects young people. Colorectal cancer (CRC) is one of the UC complications. This review considers the epidemiology, risk factors, diagnosis and screening, and drug prevention of CRC in UC. Various treatment options for dysplasia and CRC associated with UC are described. Taking into account the lack of literature to standardize colorectal cancer treatment approaches (especially rectal cancer) for UC, further studies are warranted to evaluate both oncological and functional treatment outcomes.

колоректальный ракязвенный колитдисплазияcolorectal cancerulcerative colitisdysplasiaReferencesSung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49. doi: 10.3322/CAAC.21660Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49. doi: 10.3322/CAAC.21660Ивашкин В.Т., Шелыгин Ю.А., Халиф И.Л., и соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению язвенного колита. Колопроктология. 2017:6–30. doi: 10.33878/2073-7556-2017-0-1Ivashkin V.T., Shelygin Yu.A., Khalif I.L. et al. Clinical guide of Russian association of gastroenterology and Russian Association of coloproctology on diagnostics and treatment of ulcerative colitis. Koloproctologia. 2017:6–30. (in Russ.). doi: 10.33878/2073-7556-2017-0-1Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152:313–321.e2. doi: 10.1053/J.GASTRO.2016.10.020Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152:313–321.e2. doi: 10.1053/J.GASTRO.2016.10.020Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381. e1. doi: 10.1053/J.GASTRO.2012.04.016Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381. e1. doi: 10.1053/J.GASTRO.2012.04.016Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies. Anticancer Research. Anticancer Res. 2009;29:2727–38.Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies. Anticancer Research. Anticancer Res. 2009;29:2727–38.Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010;101:706–12. doi: 10.1002/JSO.21505Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010;101:706–12. doi: 10.1002/JSO.21505Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, et al. Colonoscopy is Associated with a Reduced Risk for Colon Cancer and Mortality in Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2015;13:322. doi: 10.1016/J.CGH.2014.07.018Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, et al. Colonoscopy is Associated with a Reduced Risk for Colon Cancer and Mortality in Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2015;13:322. doi: 10.1016/J.CGH.2014.07.018Sensi B, Bagaglini G, Bellato V, Cerbo D, et al. Management of Low Rectal Cancer Complicating Ulcerative Colitis: Proposal of a Treatment Algorithm. Cancers (Basel). 2021;13. doi: 10.3390/CANCERS13102350Sensi B, Bagaglini G, Bellato V, Cerbo D, et al. Management of Low Rectal Cancer Complicating Ulcerative Colitis: Proposal of a Treatment Algorithm. Cancers (Basel). 2021;13. doi: 10.3390/CANCERS13102350Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335–42. doi: 10.1016/J.CGH.2005.12.035Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335–42. doi: 10.1016/J.CGH.2005.12.035Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, et al. Thirtyyear analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8. doi: 10.1053/J.GASTRO.2005.12.035Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, et al. Thirtyyear analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8. doi: 10.1053/J.GASTRO.2005.12.035Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Phila). 2016;9:887. doi: 10.1158/1940-6207.CAPR-16-0124Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Phila). 2016;9:887. doi: 10.1158/1940-6207.CAPR-16-0124Nebbia M, Yassin NA, Spinelli A. Colorectal Cancer in Inflammatory Bowel Disease. Clin Colon Rectal Surg. 2020;33:305–17. doi: 10.1055/S-0040-1713748Nebbia M, Yassin NA, Spinelli A. Colorectal Cancer in Inflammatory Bowel Disease. Clin Colon Rectal Surg. 2020;33:305–17. doi: 10.1055/S-0040-1713748Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526. doi: 10.1136/GUT.48.4.526Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526. doi: 10.1136/GUT.48.4.526Söderlund S, Brandt L, Lapidus A, Karlén P, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009;136:1561–7. doi: 10.1053/J.GASTRO.2009.01.064Söderlund S, Brandt L, Lapidus A, Karlén P, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009;136:1561–7. doi: 10.1053/J.GASTRO.2009.01.064Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk? World J Gastroenterol. 2012;18:3839. doi: 10.3748/WJG.V18.I29.3839Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk? World J Gastroenterol. 2012;18:3839. doi: 10.3748/WJG.V18.I29.3839Itzkowitz SH, Present DH, Binder V, Boland CR, et al. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–21. doi: 10.1097/01.MIB.0000160811.76729.D5Itzkowitz SH, Present DH, Binder V, Boland CR, et al. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–21. doi: 10.1097/01.MIB.0000160811.76729.D5Reznicek E, Arfeen M, Shen B, Ghouri Y. Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis. Dis (Basel, Switzerland). 2021;9:86. doi: 10.3390/DISEASES9040086Reznicek E, Arfeen M, Shen B, Ghouri Y. Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis. Dis (Basel, Switzerland). 2021;9:86. doi: 10.3390/DISEASES9040086Collins PD. Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:860–3. doi: 10.1097/MIB.0B013E3182802C6ACollins PD. Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:860–3. doi: 10.1097/MIB.0B013E3182802C6ACollins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006. doi: 10.1002/14651858.CD000279.PUB3Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006. doi: 10.1002/14651858.CD000279.PUB3Lutgens M, Oldenburg B, Siersema PD, Van Bodegraven AA, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101:1671. doi: 10.1038/SJ.BJC.6605359Lutgens M, Oldenburg B, Siersema PD, Van Bodegraven AA, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101:1671. doi: 10.1038/SJ.BJC.6605359Adamina M, Angriman I, Bemelman WA, Biancone L, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9:4–25. doi: 10.1016/J.CROHNS.2014.08.012Adamina M, Angriman I, Bemelman WA, Biancone L, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9:4–25. doi: 10.1016/J.CROHNS.2014.08.012Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20:9872. doi: 10.3748/WJG.V20.I29.9872Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20:9872. doi: 10.3748/WJG.V20.I29.9872Pulusu SSR, Lawrance IC. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2017;11:711–22. doi: 10.1080/17474124.2017.1327347Pulusu SSR, Lawrance IC. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2017;11:711–22. doi: 10.1080/17474124.2017.1327347Kiesslich R, Fritsch J, Holtmann M, Koehler HH, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880–8. doi: 10.1053/GAST.2003.50146Kiesslich R, Fritsch J, Holtmann M, Koehler HH, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880–8. doi: 10.1053/GAST.2003.50146Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol. 2008;14:3937. doi: 10.3748/WJG.14.3937Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol. 2008;14:3937. doi: 10.3748/WJG.14.3937Riddell RH, Goldman H, Ransohoff DF, Appelman HD, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931–68. doi: 10.1016/S0046-8177(83)80175-0Riddell RH, Goldman H, Ransohoff DF, Appelman HD, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931–68. doi: 10.1016/S0046-8177(83)80175-0Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PGK, et al. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. J Crohns Colitis. 2013;7. doi: 10.1016/J.CROHNS.2013.06.006Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PGK, et al. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. J Crohns Colitis. 2013;7. doi: 10.1016/J.CROHNS.2013.06.006Heuschen UA, Hinz U, Allemeyer EH, Stern J, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120:841–7. doi: 10.1053/GAST.2001.22434Heuschen UA, Hinz U, Allemeyer EH, Stern J, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120:841–7. doi: 10.1053/GAST.2001.22434Hurlstone DP, Sanders DS, Atkinson R, Hunter MD, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut. 2007;56:838. doi: 10.1136/GUT.2006.106294Hurlstone DP, Sanders DS, Atkinson R, Hunter MD, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut. 2007;56:838. doi: 10.1136/GUT.2006.106294Annese V, Daperno M, Rutter MD, Amiot A, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7:982–1018. doi: 10.1016/J.CROHNS.2013.09.016Annese V, Daperno M, Rutter MD, Amiot A, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7:982–1018. doi: 10.1016/J.CROHNS.2013.09.016Laine L, Kaltenbach T, Barkun A, McQuaid KR, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:639–651.e28. doi: 10.1053/J.GASTRO.2015.01.031Laine L, Kaltenbach T, Barkun A, McQuaid KR, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:639–651.e28. doi: 10.1053/J.GASTRO.2015.01.031Moss A, Bourke MJ, Williams SJ, Hourigan LF, et al. Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology. 2011;140:1909–18. doi: 10.1053/J.GASTRO.2011.02.062Moss A, Bourke MJ, Williams SJ, Hourigan LF, et al. Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology. 2011;140:1909–18. doi: 10.1053/J.GASTRO.2011.02.062Dignass A, Eliakim R, Magro F, Maaser C, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965–90. doi: 10.1016/J.CROHNS.2012.09.003Dignass A, Eliakim R, Magro F, Maaser C, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965–90. doi: 10.1016/J.CROHNS.2012.09.003Farraye FA, Odze RD, Eaden J, SH I, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45. doi: 10.1053/J.GASTRO.2009.12.037Farraye FA, Odze RD, Eaden J, SH I, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45. doi: 10.1053/J.GASTRO.2009.12.037Feakins RM. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013;66:1005–26. doi: 10.1136/JCLINPATH-2013-201885Feakins RM. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013;66:1005–26. doi: 10.1136/JCLINPATH-2013-201885Ullman TA, Croog V, Harpaz N, Sachar D, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125:1311–9. doi: 10.1016/J.GASTRO.2003.08.023Ullman TA, Croog V, Harpaz N, Sachar D, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125:1311–9. doi: 10.1016/J.GASTRO.2003.08.023O’Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004;187:343–8. doi: 10.1016/J.AMJSURG.2003.12.020O’Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004;187:343–8. doi: 10.1016/J.AMJSURG.2003.12.020Carbonnel F, Gargouri D, Lémann M, Beaugerie L, et al. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther. 2000;14:273–9. doi: 10.1046/J.1365-2036.2000.00705.XCarbonnel F, Gargouri D, Lémann M, Beaugerie L, et al. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther. 2000;14:273–9. doi: 10.1046/J.1365-2036.2000.00705.XPellino G, Keller DS, Sampietro GM, Carvello M, et al. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis. Tech Coloproctol. 2020;24:397– 419. doi: 10.1007/S10151-020-02175-ZPellino G, Keller DS, Sampietro GM, Carvello M, et al. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis. Tech Coloproctol. 2020;24:397– 419. doi: 10.1007/S10151-020-02175-ZPellino G, Keller DS, Sampietro GM, Annese V, et al. Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management. Tech Coloproctol. 2020;24:105–26. doi: 10.1007/S10151-019-02145-0Pellino G, Keller DS, Sampietro GM, Annese V, et al. Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management. Tech Coloproctol. 2020;24:105–26. doi: 10.1007/S10151-019-02145-0Frontali A, Cohen L, Bridoux V, Myrelid P, et al. Segmental Colectomy for Ulcerative Colitis: Is There a Place in Selected Patients Without Active Colitis? An International Multicentric Retrospective Study in 72 Patients. J Crohns Colitis. 2020;14:1687– 92. doi: 10.1093/ECCO-JCC/JJAA107Frontali A, Cohen L, Bridoux V, Myrelid P, et al. Segmental Colectomy for Ulcerative Colitis: Is There a Place in Selected Patients Without Active Colitis? An International Multicentric Retrospective Study in 72 Patients. J Crohns Colitis. 2020;14:1687– 92. doi: 10.1093/ECCO-JCC/JJAA107Khan N, Cole E, Shah Y, Paulson EC. Segmental resection is a safe oncological alternative to total proctocolectomy in elderly patients with ulcerative colitis and malignancy. Colorectal Dis. 2017;19:1108–16. doi: 10.1111/CODI.13721Khan N, Cole E, Shah Y, Paulson EC. Segmental resection is a safe oncological alternative to total proctocolectomy in elderly patients with ulcerative colitis and malignancy. Colorectal Dis. 2017;19:1108–16. doi: 10.1111/CODI.13721Connelly TM, Koltun WA. The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol. 2013;7:307–22. doi: 10.1586/EGH.13.17Connelly TM, Koltun WA. The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol. 2013;7:307–22. doi: 10.1586/EGH.13.17Caini S, Bagnoli S, Palli D, Saieva C, et al. Total and cancer mortality in a cohort of ulcerative colitis and Crohn’s disease patients: The Florence inflammatory bowel disease study, 1978-2010. Dig Liver Dis. 2016;48:1162–7. doi: 10.1016/J.DLD.2016.07.008Caini S, Bagnoli S, Palli D, Saieva C, et al. Total and cancer mortality in a cohort of ulcerative colitis and Crohn’s disease patients: The Florence inflammatory bowel disease study, 1978-2010. Dig Liver Dis. 2016;48:1162–7. doi: 10.1016/J.DLD.2016.07.008Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2017;28:iv22–40. doi: 10.1093/ANNONC/MDX224Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2017;28:iv22–40. doi: 10.1093/ANNONC/MDX224Sica GS, Biancone L. Surgery for inflammatory bowel disease in the era of laparoscopy. World J Gastroenterol. 2013;19:2445. doi: 10.3748/WJG.V19.I16.2445Sica GS, Biancone L. Surgery for inflammatory bowel disease in the era of laparoscopy. World J Gastroenterol. 2013;19:2445. doi: 10.3748/WJG.V19.I16.2445Remzi FH, Preen M. Rectal cancer and ulcerative colitis: does it change the therapeutic approach? Colorectal Dis. 2003;5:483–5. doi: 10.1046/J.1463-1318.2003.00505.XRemzi FH, Preen M. Rectal cancer and ulcerative colitis: does it change the therapeutic approach? Colorectal Dis. 2003;5:483–5. doi: 10.1046/J.1463-1318.2003.00505.XMerchea A, Wolff BG, Dozois EJ, Abdelsattar ZM, et al. Clinical features and oncologic outcomes in patients with rectal cancer and ulcerative colitis: a single-institution experience. Dis Colon Rectum. 2012;55:881–5. doi: 10.1097/DCR.0B013E31825BF779Merchea A, Wolff BG, Dozois EJ, Abdelsattar ZM, et al. Clinical features and oncologic outcomes in patients with rectal cancer and ulcerative colitis: a single-institution experience. Dis Colon Rectum. 2012;55:881–5. doi: 10.1097/DCR.0B013E31825BF779Monson JRT, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013;56:535–50. doi: 10.1097/DCR.0B013E31828CB66CMonson JRT, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013;56:535–50. doi: 10.1097/DCR.0B013E31828CB66CSong DY, Lawrie WT, Abrams RA, Kafonek DR, et al. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001;51:455–9. doi: 10.1016/S0360-3016(01)01629-7Song DY, Lawrie WT, Abrams RA, Kafonek DR, et al. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001;51:455–9. doi: 10.1016/S0360-3016(01)01629-7Spinelli A, Carvello M, Kotze PG, Maroli A, et al. Ileal pouch-anal anastomosis with fluorescence angiography: a case-matched study. Colorectal Dis. 2019;21:827–32. doi: 10.1111/CODI.14611Spinelli A, Carvello M, Kotze PG, Maroli A, et al. Ileal pouch-anal anastomosis with fluorescence angiography: a case-matched study. Colorectal Dis. 2019;21:827–32. doi: 10.1111/CODI.14611Zmora O, Spector D, Dotan I, Klausner JM, et al. Is stapled ileal pouch anal anastomosis a safe option in ulcerative colitis patients with dysplasia or cancer? Int J Colorectal Dis. 2009;24:1181–6. doi: 10.1007/S00384-009-0744-9Zmora O, Spector D, Dotan I, Klausner JM, et al. Is stapled ileal pouch anal anastomosis a safe option in ulcerative colitis patients with dysplasia or cancer? Int J Colorectal Dis. 2009;24:1181–6. doi: 10.1007/S00384-009-0744-9Inoue Y, Araki T, Okugawa Y, KawamotoA, et al. Chemoradiotherapy followed by restorative proctocolectomy with partial intersphincteric resection for advanced rectal cancer associated with ulcerative colitis: report of a case. Surg Today. 2014;44:387–90. doi: 10.1007/S00595-013-0558-9Inoue Y, Araki T, Okugawa Y, KawamotoA, et al. Chemoradiotherapy followed by restorative proctocolectomy with partial intersphincteric resection for advanced rectal cancer associated with ulcerative colitis: report of a case. Surg Today. 2014;44:387–90. doi: 10.1007/S00595-013-0558-9Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg. 1983;70:150–4. doi: 10.1002/BJS.1800700305Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg. 1983;70:150–4. doi: 10.1002/BJS.1800700305Guillem JG, Chessin DB, Shia J, Suriawinata A, et al. A Prospective Pathologic Analysis Using Whole-Mount Sections of Rectal Cancer Following Preoperative Combined Modality Therapy: Implications for Sphincter Preservation. Ann Surg. 2007;245:88. doi: 10.1097/01.SLA.0000232540.82364.43Guillem JG, Chessin DB, Shia J, Suriawinata A, et al. A Prospective Pathologic Analysis Using Whole-Mount Sections of Rectal Cancer Following Preoperative Combined Modality Therapy: Implications for Sphincter Preservation. Ann Surg. 2007;245:88. doi: 10.1097/01.SLA.0000232540.82364.43Hotta S, Shimada Y, Nakano M, Yamada S, et al. Feasibility of restorative proctocolectomy in patients with ulcerative colitisassociated lower rectal cancer: A retrospective study. Asian J Surg. 2019;42:267–73. doi: 10.1016/J.ASJSUR.2018.01.003Hotta S, Shimada Y, Nakano M, Yamada S, et al. Feasibility of restorative proctocolectomy in patients with ulcerative colitisassociated lower rectal cancer: A retrospective study. Asian J Surg. 2019;42:267–73. doi: 10.1016/J.ASJSUR.2018.01.003Fazio VW, Kiran RP, Remzi FH, Coffey JC, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257:679–85. doi: 10.1097/SLA.0b013e31827d99a2Fazio VW, Kiran RP, Remzi FH, Coffey JC, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257:679–85. doi: 10.1097/SLA.0b013e31827d99a2Rouanet P, Rivoire M, Gourgou S, Lelong B, et al. Sphinctersaving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up? J Surg Oncol. 2021;123:299–310. doi: 10.1002/JSO.26249Rouanet P, Rivoire M, Gourgou S, Lelong B, et al. Sphinctersaving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up? J Surg Oncol. 2021;123:299–310. doi: 10.1002/JSO.26249Park JS, Park SY, Kim HJ, Cho SH, et al. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer. Dis Colon Rectum. 2019;62:408–16. doi: 10.1097/DCR.0000000000001321Park JS, Park SY, Kim HJ, Cho SH, et al. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer. Dis Colon Rectum. 2019;62:408–16. doi: 10.1097/DCR.0000000000001321Lorenzi B, Brading AF, Martellucci J, Cetta F, et al. Short-term effects of neoadjuvant chemoradiotherapy on internal anal sphincter function: a human in vitro study. Dis Colon Rectum. 2012;55:465–72. doi: 10.1097/DCR.0B013E31824154A0Lorenzi B, Brading AF, Martellucci J, Cetta F, et al. Short-term effects of neoadjuvant chemoradiotherapy on internal anal sphincter function: a human in vitro study. Dis Colon Rectum. 2012;55:465–72. doi: 10.1097/DCR.0B013E31824154A0Ito M, Saito N, Sugito M, Kobayashi A, et al. Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. Dis Colon Rectum. 2009;52:64–70. doi: 10.1007/DCR.0B013E31819739A0Ito M, Saito N, Sugito M, Kobayashi A, et al. Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. Dis Colon Rectum. 2009;52:64–70. doi: 10.1007/DCR.0B013E31819739A0Reynolds IS, O’Toole A, Deasy J, McNamara DA, et al. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer. Int J Colorectal Dis. 2017;32:443–51. doi: 10.1007/S00384-017-2754-3Reynolds IS, O’Toole A, Deasy J, McNamara DA, et al. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer. Int J Colorectal Dis. 2017;32:443–51. doi: 10.1007/S00384-017-2754-3Thicoïpé A, Laharie D, Smith D, Chabrun E, et al. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study. Int J Colorectal Dis. 2018;33:963–6. doi: 10.1007/S00384-018-3049-ZThicoïpé A, Laharie D, Smith D, Chabrun E, et al. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study. Int J Colorectal Dis. 2018;33:963–6. doi: 10.1007/S00384-018-3049-Z

The authors declare that there are no conflicts of interest present.